Showing results (1-10 of 321) with videos related to
Sort By:
Pageof 33
Nature|May 28, 2004
Moving towards individualized medicine with pharmacogenomicsWilliam E Evans, Mary V RellingBest Practice & Research. Clinical Haematology|March 6, 2003
Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemiaChing Hon Pui, Mary V Relling, William E EvansReviews in Clinical and Experimental Hematology|August 28, 2002
Childhood acute lymphoblastic leukemiaChing-Hon Pui, Mary V Relling, Dario Campana, et al.Blood|June 26, 2012
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?Ching-Hon Pui, Charles G Mullighan, William E Evans, et al.Plos Computational Biology|December 15, 2010
Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cellsJohn C Panetta, Alex Sparreboom, Ching-Hon Pui, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activityJohn Carl Panetta, Amelia Wall, Ching-Hon Pui, et al.Clinical Chemistry|December 26, 2001
HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapyThierry Dervieux, Yaqin Chu, Yi Su, et al.Nature Genetics|July 26, 2005
Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypesQing Cheng, WenJian Yang, Susana C Raimondi, et al.Cancer Chemotherapy and Pharmacology|June 18, 2017
Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicityChengcheng Liu, Laura J Janke, Jun J Yang, et al.Pageof 33